Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pepgen
company
About
Pepgen is a privately-held biopharmaceutical company that develops novel products for the treatment of autoimmune and viral disorders.
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $7.50M
- Industries
- Biopharma,Medical,Pharmaceutical
- Founded date
- Jan 1, 1992
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pepgen is a privately-held biopharmaceutical company that develops and commercializes novel products for the prevention and treatment of autoimmune and viral disorders.It was founded in 1992 by Chih-Ping Liu and is based in Alameda, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$7.50M
Pepgen has raised a total of
$7.50M
in funding over 2 rounds. Their latest funding was raised on
Aug 3, 2004 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 3, 2004 | Series D | $7.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Pepgen is funded by 2 investors.
Biotechnology Development Fund VI, L.P.
and Veron International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
